One subsequent analysis has estimated that 7.9 million individuals meet the SELECT trial criteria in the US: Among these individuals, treatment with semaglutide could prevent about 190 000 cardiovascular events in 5 years. If each eligible patient received semaglutide at a retail price of $16 188 per year, the total cost would amount to $127 billion per year. The authors of SELECT noted that: Potentially less costly alternatives for reducing obesity and CVD risk include lifestyle counseling, dietary fasting, and alternative pharmacological weight loss approaches
Diminished UPR activation at both the protein (Figure 8C) and mRNA (Figure 8D) levels indicated that MPC1-deficient cells were also remarkably resistant to ER stress induced by TM or by the ER calcium-disrupting agent thapsigargin (TG)
Research suggests that IGF1 LR3 and follistatin may have paired effects, with IGF1 LR3 actively promoting muscle growth through anabolic signaling while follistatin removes inhibitory signals
GLP-1 medications, such as semaglutide (Wegovy) or liraglutide (Saxenda), are often used for weight loss and managing type 2 diabetes, but they can be expensive
He likes that, because I get to see how shots went, and Ill look through the comments and see reactions
Contraindications include medullary thyroid cancer and multiple endocrine neoplasia 2 (the same for Wegovy and Ozempic)
